CD8-Targeted, Integrating Viral Vectors Transduce Resting T Cells and Enable Extracorporeal Delivery (ECD) for Rapid CAR T Cell Therapies

Jesse Green(Sana Biotechnology (United States)), Terry J. Fry(University of Colorado Anschutz Medical Campus), Jesus Moreno(Sana Biotechnology (United States)), Hallee Wright(Sana Biotechnology (United States)), Brian Dolinski(Sana Biotechnology (United States)), Semih U. Tareen(Metis Design Corporation (United States)), Jagesh V. Shah(Brigham and Women's Hospital), Aaron E. Foster(Medpace (United States)), Kutlu G. Elpek(Sana Biotechnology (United States)), Hanane Ennajdaoui(Mount Sinai Hospital), Brian Granger(Sana Biotechnology (United States)), Adam Johnson(Sana Biotechnology (United States)), Andrew Tucker(Sana Biotechnology (United States)), Ouwen Liang(Sana Biotechnology (United States)), Neal Van Hoeven(Sana Biotechnology (United States))
Blood
November 15, 2022
Cited by 5


Related Papers